Related Experiment Video
Updated: Apr 6, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer
Qi-guang Chen1, Wei Zhou2, Tao Han3
1Department of Urology, The First Affiliated Hospital of China Medical University, Nanjing Street 155#, Shenyang, 110001, Liaoning, China.
Introduction:
The roles of dysregulated microRNAs in prostate cancer metastasis are still unknown. In this study, we found that the expression of miR-345 was significantly downregulated in prostate cancer and clinical prostate cancer tissues.
Materials, Methods And Results:
Overexpression of miR-345 in prostate cancer cells suppressed proliferation, migration and invasion. Using nude mice model, we revealed that miR-345 inhibits the growth of prostate cancer cells in vivo and in vitro. Furthermore, we identified and validated Smad1 as a direct target of miR-345. Ectopic expression of Smad1 without its 3'-UTR rescued miR-345-induced cell migration and invasion inhibition.
Conclusion:
Taken together, our data suggest that miR-345 exerts a suppressive effect on prostate cancer proliferation, invasion and migration through downregulation of Smad1.
Insights
MicroRNA-345 (miR-345) is downregulated in prostate cancer, suppressing tumor growth, migration, and invasion by targeting Smad1. This finding offers new insights into prostate cancer metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Dysregulated microRNAs (miRNAs) play roles in cancer metastasis, but their specific involvement in prostate cancer remains unclear.
- This study investigates the expression and function of miR-345 in prostate cancer progression.
Purpose of the Study:
- To determine the role of miR-345 in prostate cancer proliferation, migration, and invasion.
- To identify the molecular targets of miR-345 in prostate cancer.
Main Methods:
- Quantitative real-time PCR to assess miR-345 expression in prostate cancer tissues and cell lines.
- In vitro assays (proliferation, migration, invasion) to evaluate the functional effects of miR-345.
- In vivo studies using a nude mice model to assess tumor growth inhibition.
- Luciferase reporter assays and Western blotting to identify and validate Smad1 as a direct target of miR-345.
Main Results:
- miR-345 expression was significantly downregulated in prostate cancer tissues and cell lines.
- Overexpression of miR-345 suppressed prostate cancer cell proliferation, migration, and invasion in vitro.
- miR-345 inhibited prostate cancer growth in vivo.
- Smad1 was identified as a direct target of miR-345, and its re-expression rescued the suppressive effects of miR-345 on cell migration and invasion.
Conclusions:
- miR-345 acts as a tumor suppressor in prostate cancer.
- The suppressive effects of miR-345 on prostate cancer progression are mediated through the downregulation of Smad1.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

